---
title: "ELAN PHARMA INTERNATIONAL LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e8a67b9e-8b99-50c6-9fd8-bb4ce47f1617
json: https://whiteintel.dev/api/public/dossier/e8a67b9e-8b99-50c6-9fd8-bb4ce47f1617
identifier: sec:0001307004
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ELAN PHARMA INTERNATIONAL LTD

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001307004`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e8a67b9e-8b99-50c6-9fd8-bb4ce47f1617  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e8a67b9e-8b99-50c6-9fd8-bb4ce47f1617  

## Ownership & control

### Holdings / subsidiaries

- **KINETA, INC./DE** (tenpercentowner) — https://whiteintel.dev/entity/4dd181ee-17d5-53c8-bb79-9bbeeebd1df6
- **Lipocine Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/0f34df4a-5698-5d49-b785-07f483a72886

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ELAN PHARMA INTERNATIONAL LTD**. Human view: https://whiteintel.dev/entity/e8a67b9e-8b99-50c6-9fd8-bb4ce47f1617 · Structured JSON: https://whiteintel.dev/api/public/dossier/e8a67b9e-8b99-50c6-9fd8-bb4ce47f1617._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._